ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,385.45
0.18%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Xaar Plc (XAR) Cotización

Xaar Plc

Xaar Plc (XAR)

SPDR S&P Aerospace and Defense
81.00
-2.20
(-2.64%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
81.00
Postura de Compra
81.20
Postura de Venta
83.80
Volume Operado de la Acción
15,808
81.20 Rango del Día 81.20
66.00 Rango de 52 semanas 150.00
Capitalización de Mercado [m]
64.378M
Precio Anterior
83.20
Precio de Apertura
81.20
Hora
2
@
81
(UT)
Última hora de negociación
Volumen financiero
12,836p
Precio Promedio Ponderado
81.1999
Volumen promedio (3 m)
79,971
Acciones en circulación
79,479,189
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-29.64
Beneficio por acción (BPA)
-0.03
turnover
70.61M
Beneficio neto
-2.17M

Acerca de Xaar Plc

Sector
Commercial Printing, Nec
Industria
Printing Diversified
Sitio web
www.xaar.com
Sede
Cambridge, Gbr
Fundado
1997
Xaar Plc is listed in the Commercial Printing sector of the London Stock Exchange with ticker XAR. The last closing price for Xaar was 83.20p. Over the last year, Xaar shares have traded in a share price range of 66.00p to 150.00p.

Xaar currently has 79,479,189 shares in issue. The market capitalisation of Xaar is £66.13 million. Xaar has a price to earnings ratio (PE ratio) of -29.64.

XAR Últimas noticias

Más noticias

Xaar PLC 2024 Full Year Trading Update

Xaar PLC 11 December 2024   11 December 2024   Xaar plc   2024 FULL YEAR TRADING UPDATE     Xaar plc ("Xaar", the "Group" or the "Company"), the leading inkjet printing technology group...

11 Diciembre 2024
RNS Regulatory News

Xaar PLC Update statement on 2024 AGM voting results

Xaar PLC 04 December 2024   4 December 2024     Xaar plc (the "Company")   Update statement on 2024 Annual General Meeting voting results   Xaar plc ("Xaar" or "the Group" or "the Company...

04 Diciembre 2024
RNS Regulatory News

Xaar PLC Total Voting Rights

Xaar PLC 03 December 2024   Xaar plc 3 December 2024 Total Voting Rights In accordance with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rule 5.6.1, Xaar plc (the...

03 Diciembre 2024
RNS Regulatory News

EXECUTIVE CHANGES: Vistry COO exits in revamp; Ebiquity picks new CEO

The following is a round-up of London-listed company director and manager changes announced this week and not separat ...

20 Noviembre 2024
Alliance News

Xaar PLC Board changes

Xaar PLC 20 November 2024   20 November 2024   Xaar plc   Board changes   Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, announces that Ian...

20 Noviembre 2024
RNS Regulatory News

Xaar PLC Total Voting Rights

Xaar PLC 01 November 2024   Xaar plc 1 November 2024 Total Voting Rights In accordance with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rule 5.6.1, Xaar plc (the...

01 Noviembre 2024
RNS Regulatory News

Xaar PLC Total Voting Rights

Xaar PLC 01 October 2024   Xaar plc 1 October 2024 Total Voting Rights In accordance with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rule 5.6.1, Xaar plc (the...

01 Octubre 2024
RNS Regulatory News

Xaar interim revenue falls amid ceramic market uncertainty

Xaar PLC on Wednesday said its revenue for the first half of 2024 has fallen due to a declining ceramics market, desp ...

18 Septiembre 2024
Alliance News

Xaar PLC Interim Results

Xaar PLC 18 September 2024   18 September 2024   Xaar plc   2024 INTERIM RESULTS   RESILIENT PERFORMANCE AGAINST A DIFFICULT MARKET BACKDROP   Xaar plc ("Xaar", the "Group" or the "Company...

18 Septiembre 2024
RNS Regulatory News

Xaar PLC Total Voting Rights

Xaar PLC 02 September 2024   Xaar plc 2 September 2024 Total Voting Rights In accordance with the Financial Conduct Authority's ("FCA") Disclosure and Transparency Rule 5.6.1, Xaar plc (the...

02 Septiembre 2024
RNS Regulatory News
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
19.813.764044943871.284714847981.22283566DE
47.410.054347826173.68470.23109376.75932789DE
12-22.5-21.7391304348103.5104667997182.3305019DE
26-67.5-45.4545454545148.5150666190495.3990603DE
52-30.5-27.3542600897111.51506684425107.52005972DE
156-101-55.494505494518227566117578170.41690823DE
2602852.83018867925327518.7224032127.04122431DE

XAR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Xaar?
El precio actual de las acciones de Xaar es 81.00p
¿Cuántas acciones de Xaar están en circulación?
Xaar tiene 79,479,189 acciones en circulación
¿Cuál es la capitalización de mercado de Xaar?
La capitalización de mercado de Xaar es GBP 66.13M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Xaar?
Xaar ha negociado en un rango de 66.00p a 150.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Xaar?
El ratio precio/beneficio de Xaar es -29.64
¿Cuál es el ratio de efectivo a ventas de Xaar?
El ratio de efectivo a ventas de Xaar es 0.91
¿Cuál es la moneda de reporte de Xaar?
Xaar presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Xaar?
El último ingresos anual de Xaar es GBP 70.61M
¿Cuál es el último beneficio anual de Xaar?
El último beneficio anual de Xaar es GBP -2.17M
¿Cuál es la dirección registrada de Xaar?
La dirección registrada de Xaar es 3950 CAMBRIDGE RESEARCH PARK, WATERBEACH, CAMBRIDGE, CB25 9PE
¿Cuál es la dirección del sitio web de Xaar?
La dirección del sitio web de Xaar es www.xaar.com
¿En qué sector industrial opera Xaar?
Xaar opera en el sector PRINTING DIVERSIFIED

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
Investor2014 Investor2014 3 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 9 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 10 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 14 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 17 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 17 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 20 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 22 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 25 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 26 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 27 minutos hace
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 28 minutos hace
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 30 minutos hace
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 44 minutos hace
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 45 minutos hace
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 45 minutos hace
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 48 minutos hace
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX
CometNebula81 CometNebula81 50 minutos hace
What is everyone's opinion on if or when dividends may be restored and if so what much would we be looking at in dividends? Let's you have 100,000 shares what would you be getting every year?
FNMA
Steady_T Steady_T 50 minutos hace
Wouldn't the MABS have to be better than donepezil and memantine to get approved making them the new SOC?

That doesn't mean the MABS are selling well.
AVXL
mrwhippy458 mrwhippy458 51 minutos hace
Somewhat true. Once it's at 250m OS, they need to bring that market cap up so we can start seeing dollars
ABQQ
CrossFireTrader CrossFireTrader 54 minutos hace
Actually Alocations are given to Dealerships based on how many Vettes they have sold in prior years 25 years ago I lived in Los Angeles and there was a small city Montclair about 10 15 south of Pasadena there was a Dealership there Richard Hibbard Chevrolet and he got more Vettes than anyone in the
GDVM
Roman516 Roman516 56 minutos hace
NWBO stock price manipulation NoGro,

Per your comments,
"NWBO share price dropped 58% i 52 weeks -- That means that longs are SELLING as they don't have confidence in the future of the company. No cash, vulture investors diluting shareholders, no real commercial prospects (UK i
NWBO
WATERFALL1 WATERFALL1 58 minutos hace
GVSI is uptrend stock already

Alligator opened the mouth on Dec.-06-2024
GVSI
StockItOut StockItOut 59 minutos hace
you're extrapolating. And youre attempt8ng to place it without understanding the reality of the contract in which its terms act.
XERI

Su Consulta Reciente

LSE
XAR
Xaar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados